Celularity CELU
NASDAQ CELU
$1.42 -0.02 (-1.39%)
As of: Sep 10, 2026 · 3:53 PM EDT

Celularity (CELU) Other Non-Current Assets (2018 - 2025)

Celularity's (CELU) quarterly Other Non-Current Assets came in at $10.2 million in Q4 2025, little changed year-over-year from $10.2 million in Q4 2024, and up 0.61% quarter-over-quarter from $10.1 million in Q3 2025.

Analysis

Celularity (CELU) Other Non-Current Assets (2018 - 2025) Analysis & Trends

Celularity (CELU) has reported Other Non-Current Assets for 7 consecutive years, with $10.2 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.41% year-over-year to $10.2 million in Q4 2025; TTM through Dec 2025 was $10.2 million, a 0.41% change from a year earlier, with the FY2025 full-year figure at $10.2 million, changed 0.41% from the prior year.
  • Other Non-Current Assets was $10.2 million for Q4 2025 at Celularity, up from $10.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $14.8 million in Q4 2021 and troughed at $9.9 million in Q4 2023.
  • A 5-year average of $12.5 million and a median of $12.5 million in 2021 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets sank 33.03% in 2023 and gained 3.05% in 2024, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $14.8 million in 2021, then changed by 0.0% to $14.8 million in 2022, then tumbled by 33.03% to $9.9 million in 2023, then gained by 3.05% to $10.2 million in 2024, then dropped by 0.41% to $10.2 million in 2025.
  • The last three Other Non-Current Assets figures came in at $10.2 million (Q4 2025), $10.1 million (Q3 2025), and $10.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Krystal Biotech 10.26 Bn 9.41 Bn 112.79 Mn 284,000.00
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 37.71 Mn
3 Iovance Biotherapeutics 3.66 Bn 3.36 Bn 55.72 Mn 6.43 Mn
4 Legend Biotech 3.55 Bn 2.58 Bn 251.50 Mn 25.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 4.54 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn - 7.86 Mn
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn 708,000.00
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 146.15 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 233,000.00
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn 10.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.20 Mn
Sep 30, 2025 10.14 Mn
Jun 30, 2025 10.07 Mn
Mar 31, 2025 10.01 Mn
Dec 31, 2024 10.24 Mn
Sep 30, 2024 10.16 Mn
Jun 30, 2024 10.09 Mn
Mar 31, 2024 10.05 Mn
Dec 31, 2023 9.94 Mn
Sep 30, 2023 14.83 Mn
Jun 30, 2023 14.83 Mn
Mar 31, 2023 14.83 Mn
Dec 31, 2022 14.84 Mn
Sep 30, 2022 14.83 Mn
Jun 30, 2022 14.83 Mn
Mar 31, 2022 14.83 Mn
Dec 31, 2021 14.84 Mn
Sep 30, 2021 14.72 Mn
Dec 31, 2020 15.20 Mn
Dec 31, 2018 149,750.00